- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0148942

Respipure Pharma Private Limited
About Respipure Pharma Private Limited
Data last updated:
Respipure Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Trihal Pharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC375528. Its GSTIN is 27AALCR5961R1ZB (Maharashtra).
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shekhar Shrawankumar Bhuwania and Manish Shah Mangilal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9 Cr and EBITDA of -₹3.63 Cr.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹77.43 Cr on record.
Respipure Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0148942).
Company details
Recognitions & Rankings of Respipure Pharma
Contact details
Respipure Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Respipure Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Respipure Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Respipure Pharma Private Limited, buy the company report.
Financials of Respipure Pharma Private Limited
FY 2025 filings availableRespipure Pharma Private Limited reported revenue of ₹45.41 Lakh (up 1202% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.63 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹9 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Respipure Pharma Private Limited, buy the company report.
Board of directors of Respipure Pharma Private Limited
Respipure Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shekhar Shrawankumar Bhuwania Also directs: Oc Bioscience Private Limited, Trihal Pharma Private Limited, Growlease Fintech I LLP and 5 more | Director | 15 Jun 2022 | 4 Years 5 Months | Current |
| Manish Shah Mangilal Also directs: Indira Consultancy LLP, Oc Bioscience Private Limited, Oc Specialities Private Limited and 4 more | Director | 27 Jan 2022 | 4 Years 9 Months | Current |
| Nishant Vaish Also directs: Aryann Chemical Trading Private Limited | Director | 27 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Respipure Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Puerile Dermaceuticals Private Limited | ₹46.43 Lakh (FY 2025) | 222.0% | Gurgaon, Haryana, India | |||
| Smitha Braun Laboratories Private Limited | ₹46.37 Lakh (FY 2025) | 37.0% | Wagholi, Maharashtra, India | |||
| Chittaranjan Chemicals Pvt Ltd | ₹46.27 Lakh (FY 2025) | 7.0% | Pune, Maharashtra, India | |||
| Glomecare Pharmaceutical Private Limited | ₹46.2 Lakh (FY 2025) | 86.0% | Thane, Maharashtra, India | |||
| ZNT Chemicals Private Limited | ₹45.88 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Respipure Pharma Private Limitedthis company | ₹45.41 Lakh (FY 2025) | -₹9 Cr | 1202.0% | 26 | Mumbai, Maharashtra, India | |
| RBN Organics Private Limited | ₹45.29 Lakh (FY 2025) | -5.0% | Mumbai, Maharashtra, India | |||
| Ion Treat Engineers Private Limited | ₹44.94 Lakh (FY 2024) | Delhi, India | ||||
| Aurapha Private Limited | ₹44.74 Lakh (FY 2025) | 980.0% | Rajapalayam, Tamil Nadu, India | |||
| Chemex Industries Private Limited | ₹44.59 Lakh (FY 2025) | 46.0% | Nashik, Maharashtra, India | |||
| Krithvi Lub Industries Private Limited | ₹44.17 Lakh (FY 2025) | 2.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Respipure Pharma Private Limited, buy the company report.
Auditor
Respipure Pharma Private Limited is audited by VANITA BHUVA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VANITA BHUVA & CO | FY 2023 | 145476W |
Shareholding
The shareholding of Respipure Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Respipure Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101109538 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 18 Oct 2023 | 100806250 | Hdfc Bank Limited | ₹38.64 Cr | Open | |
| 19 Dec 2022 | 100657340 | Hdfc Bank Limited | ₹38.64 Cr | Open |
To see the full charge records of Respipure Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Respipure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Respipure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Respipure Pharma Private Limited has a workforce of 26 employees on its EPFO records as of Feb 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 26 |
GST
Respipure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCR5961R1ZB | Maharashtra | Active | 01 Mar 2022 |
To see the full GST registrations and return filing status of Respipure Pharma Private Limited, buy the company report.
Recent activity
Respipure Pharma Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Shekhar Shrawankumar Bhuwania ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Respipure Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2022 (4+ years old) and is registered under CIN U24290MH2022PTC375528.
Respipure Pharma has 3 current directors:
- Shekhar Shrawankumar Bhuwania - Director
- Manish Shah Mangilal - Director
- Nishant Vaish - Director
The latest financial statements of Respipure Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Respipure Pharma is 27AALCR5961R1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Respipure Pharma is U24290MH2022PTC375528. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Respipure Pharma was incorporated on 27 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Respipure Pharma by revenue are Puerile Dermaceuticals Private Limited, Smitha Braun Laboratories Private Limited, Chittaranjan Chemicals Pvt Ltd, Glomecare Pharmaceutical Private Limited, ZNT Chemicals Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Shekhar Shrawankumar Bhuwania ceased to be Additional Director on 29 Sep 2023. Shekhar Shrawankumar Bhuwania was appointed as Director on 15 Jun 2022. Manish Shah Mangilal was appointed as Director on 27 Jan 2022. Respipure Pharma has 4 board changes on record in total.
Yes, Respipure Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0148942).
The registered office of Respipure Pharma is at Shop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
Respipure Pharma operates in the pharma industry, in the drug formulation and development segment.

